Immunome Bio (IMNM) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
GURU.Markets grafigidagi 0.01 ko'rsatkichiga ega bo'lgan Immunome, Inc. (IMNM) kompaniyasining tasdiqlangan narxlar tarixi immunologik dori vositalarini ishlab chiqishga yo'naltirilgan biznesni aks ettiradi. Firmaning raqobatlashish qobiliyati sog'aygan shaxslarning B-hujayralaridan antitanalarni ajratib olishning noyob usuliga asoslangan. Qat'iy FDA nazoratiga qaramay, AQShdagi qat'iy patent cheklovlari va lobbiistlarning qo'llab-quvvatlashi bozorga kirishni qiyinlashtiradi. Xatarlar bir nechta mustaqil onkologiya dasturlari portfeli orqali yumshatiladi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_IMNM_-_Immunome-Inc._-_Long-Term-Debt-to-Capital "IMNM: Immunome Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
Immunome, Inc. (IMNM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Immunome, Inc.|IMNM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati immunome.com|IMNM - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Immunome, Inc.|IMNM - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Immunome|Tezkor likvidlik ko‘rsatkichi immunome.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Immunome Inc - IMNM
Immunome, Inc. (IMNM) ning biofarmatsevtika biznesi uchun uzoq muddatli qarzdorlikning kapitalga nisbati kompaniya musbat erkin pul oqimiga erishguniga qadar antitanalar ishlab chiqish uchun moliyalashtirish strategiyasini aks ettiradi. Ushbu ko'rsatkich muddati bir yildan oshadigan majburiyatlarni aksiyadorlar kapitali bilan taqqoslaydi, bu esa investorlarga klinik sinovlarning kengayishi davomida kompaniyaning moliyaviy mustaqillik darajasini va qarz yuklamasi risklarini baholash imkonini beradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Pieris Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Savara Pharma SVRA|Rigel Pharmaceuticals (RIGL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati anaptysbio.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Astria Therapeutics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati enGene Holdings Inc (ENGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT (RAPT Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati aerovatetx.com (JBIO)|Uzoq muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics ACRS|KYTX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|TLSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cabaletta Bio Inc.|Ventyx Bio (VTYX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Theratechnologies, Inc|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati eledon.com ELDN|Uzoq muddatli qarzning o'z kapitaliga nisbati AGEN (Agenus Inc.)|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzdorlikning kapitalga nisbati aTyr Pharmaceuticals (ATYR)|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|IMA (ImageneBio Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|STTK: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Equillium|Uzoq muddatli qarzning o'z kapitaliga nisbati CNTB|Immunic Inc (IMUX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ATRA|Uzoq muddatli qarzdorlikning kapitalga nisbati inflarx.de|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|CELU - Uzoq muddatli qarzning o'z kapitaliga nisbati|INMB (INmune Bio Corporation) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Barinthus Biotherapeutics (BRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati kezarlifesciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics, Inc.|Akari Therapeutics PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|QTTB (q32bio.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|Uzoq muddatli qarzning kapitalga nisbati edesabiotech.com EDSA|IBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CARM (Carisma Therapeutics)|XTL Biopharmaceuticals, Ltd. (XTLB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics, Inc.|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Aptevo|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM (AIM ImmunoTech)|ADTX (aditxt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzdorlikning kapitalga nisbati XORTX Corp (XRTX)|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|revbiosciences.com (REVB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Scinai Immunotherapeutics Ltd|Uzoq muddatli qarzning o'z kapitaliga nisbati CALI|Uzoq muddatli qarzning kapitalga nisbati Affimed Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|iTeos Therapeutics Inc (ITOS) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TC BioPharm Ltd TCBP|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati